Alejandro Berlin

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.

Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.

Journal: BMC cancer

Published: November 09, 2023

Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer Network.

Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer Network.

Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica

Published: June 19, 2023

Virtual care for prostate cancer survivorship: protocol for an evaluation of a nurse-led algorithm-enhanced virtual clinic implemented at five cancer centres across Canada.

Virtual care for prostate cancer survivorship: protocol for an evaluation of a nurse-led algorithm-enhanced virtual clinic implemented at five cancer centres across Canada.

Journal: BMJ open

Published: April 22, 2021

Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer.

Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer.

Journal: Nature medicine

Published: September 23, 2020

[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.

[18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.

Journal: BMJ open

Published: April 25, 2020

A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes.

A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes.

Journal: International journal of radiation oncology, biology, physics

Published: November 06, 2018

Quantitative assessment of dynamic 18F-flumethycholine PET and dynamic contrast enhanced MRI in high risk prostate cancer.

Quantitative assessment of dynamic 18F-flumethycholine PET and dynamic contrast enhanced MRI in high risk prostate cancer.

Journal: The British journal of radiology

Published: November 02, 2018

Radiosurgery and risk of intracranial malignancies: more research needed.

Radiosurgery and risk of intracranial malignancies: more research needed.

Journal: The Lancet. Oncology

Published: September 10, 2018

International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.

International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.

Journal: The Journal of urology

Published: August 29, 2018

ONECUT2 is a driver of neuroendocrine prostate cancer.

ONECUT2 is a driver of neuroendocrine prostate cancer.

Journal: Nature communications

Published: August 02, 2018

Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.

Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.

Journal: Clinical genitourinary cancer

Published: July 23, 2018

Significance of treatment response when managing patients with primary central nervous system lymphoma.

Significance of treatment response when managing patients with primary central nervous system lymphoma.

Journal: Leukemia & lymphoma

Published: July 04, 2018

Showing 1-12 of 56

Last Updated: 09/26/2026